VEGFA and metastatic prostate carcinoma: To clarify differences in VEGF‐A levels over time, we performed a linear regression analysis, with the addition of data from archived plasma samples from patients who were treated with docetaxel/ADT alone for metastatic prostate cancer (controls, nine samples from six unique patients).